PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing
Recruiting · NCT02282969 · Observational (researchers observe without assigning treatment) · Lead sponsor: M.D. Anderson Cancer Center
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Objectives: This protocol addresses the first phase of a larger project funded by the Patient-Centered Outcomes Research Institute to help heavy smokers make informed decisions about lung cancer screening with low-dose computed tomography (CT). A separate IRB protocol will be submitted for the larger, comparative study. In this initial development phase, our prototype patient decision aid will be updated to reflect current guidelines about lung cancer screening. The updated aid will then be pilot-tested in a new sample of patients. In addition, several of the study measures will be refined and further developed in preparation for the larger study. The specific aims of the measures and decision aid development phase of this project are as follows: Update the aid to reflect current screening guidelines and refine the aid via cognitive testing with patients/smokers; and pilot test the updated aid for acceptability with patients/smokers. Modify our current measure of lung cancer knowledge, conduct cognitive testing of the new measure with patients/smokers, and evaluate the reliability of the new measure in a sample patients/smokers.
Who can take part
Inclusion criteria
- Men and women 55 to 80 years of age.
- Participants must speak English.
- Current smoker or quit smoking within the past 15 years.
Exclusion criteria
- \. History of lung cancer.
Where it is running
2 locations listed across 1 US state.
- The University of Texas Medical Branch at Galveston - Galveston, Texas, United States
- University of Texas MD Anderson Cancer Center - Houston, Texas, United States